Filters
Save & Share
Clear Filters
Location
Explore options near your home - or near family and friends.
Trial Enrollment Status
Trials Near Add Your Location
Accepting patients
Cabozantinib
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 2
- Has results
Accepting patients
TAPUR
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Learn more- Phase 2
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
CARE Study
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 1/2
- Has results
Accepting patients
Larotrectinib
Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 2
- PI3K Inhibitor
- Tyrosine Kinase (TK) Inhibitor
- Phase 2
Accepting patients
TRIDENT-1
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 1/2
- Has results
Accepting patients
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Learn more- Phase 2
Accepting patients
NAUTIKA1: Multicenter, Phase II, Neoadjuvant and Adjuvant Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer
Learn more- Phase 2
Accepting patients
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
Learn more- Phase 2
Accepting patients
A Phase II, Open-Labeled, Multi-Center, Randomized Controlled Trial of Vinblastine +/- Bevacizumab for the Treatment of Chemotherapy-Naïve Children With Unresectable or Progressive Low Grade Glioma (LGG)
Learn more- Randomization
- Phase 2
1 trials are hidden based on your filters. Show All